VOYA Investment Management’s Aquestive Therapeutics AQST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$72.5K Hold
17,472
﹤0.01% 2233
2025
Q4
$113K Buy
17,472
+928
+6% +$5.78K ﹤0.01% 2244
2025
Q3
$92.5K Sell
16,544
-8,083
-33% -$34.9K ﹤0.01% 2314
2025
Q2
$81.5K Buy
24,627
+4,411
+22% +$12.7K ﹤0.01% 2530
2025
Q1
$58.6K Sell
20,216
-3,485
-15% -$10.6K ﹤0.01% 2526
2024
Q4
$84.4K Sell
23,701
-1,214
-5% -$5.6K ﹤0.01% 2612
2024
Q3
$124K Sell
24,915
-926
-4% -$3.6K ﹤0.01% 2611
2024
Q2
$67.2K Buy
+25,841
New +$86.3K ﹤0.01% 2753
2021
Q2
Sell
-10,040
Closed -$52K 2808
2021
Q1
$52K Buy
+10,040
New +$53.4K ﹤0.01% 2742

Other funds holding AQST

VOYA Investment Management's AQST Position: Q1 2026 in Review

VOYA Investment Management held its Aquestive Therapeutics (AQST) position steady in Q1 2026 at 17,472 shares worth $72.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2233.

VOYA Investment Management first reported a position in AQST in Q1 2021 and has held it in 9 quarters since. The position peaked at $124K in Q3 2024. 179 funds tracked by Wall St. Rank hold AQST as of Q1 2026.

  • VOYA Investment Management held 17,472 shares of Aquestive Therapeutics worth $72.5K as of Q1 2026.
  • VOYA Investment Management left its Aquestive Therapeutics share count unchanged in Q1 2026.
  • Aquestive Therapeutics made up ﹤0.01% of VOYA Investment Management's portfolio in Q1 2026, its #2233 holding.
  • VOYA Investment Management first reported a position in Aquestive Therapeutics in Q1 2021 and has held it in 9 quarters since.
  • VOYA Investment Management's Aquestive Therapeutics position peaked at $124K in Q3 2024.
  • 179 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.